Global Histology and Cytology Market Forecast to 2030 - Covid-19 Impact Analysis (By Type Of Examination: Histology, Cytology; By Product: Instruments and Analysis Software System, Consumable and Reagents; and By Application: Drug Discovery & Designing, Clinical Diagnostics, Research) - Global Market Size, Industry Trends, Competitive Landscape, and Opportunities
The Global Histology and Cytology Market size accounted for USD 20,071 Mn in 2021 and is projected to reach USD 58,461 Mn by 2030 with a CAGR of 12.8% from 2022 to 2030.
Histology is a branch of biology that researches tissues of plants and animals under the microscope, whereas cytology is a further branch of biology that researches cells under the microscope. Furthermore, histological studies are more extensive, detailed, and costly than cytological studies. Cytology is divided into two branches. There are those involved in gynecological cytology, which is the assessment of pre-cancerous and, on occasion, cancerous alterations of the cervix (mouth of the womb), such as in cervical cancer screening.
Histology is the investigation of tissues under the microscope, whereas cytology is the examination of cells. Histology provides excellent tissue architecture details, whereas cytology gives better cellular details. Histological studies, on the other hand, are more comprehensive than cytological studies. As a result, histological studies are more expensive than cytological studies. However, both types of research are essential branches of biology. As a result, this summarizes the distinctions among histology and cytology.
The increasing incidence of cancer and infectious diseases like tuberculosis, smallpox, Human papillomavirus (HPV) infection, and others will drive the worldwide histology and cytology market growth during the forecast. According to World Health Organization (WHO) statistics, approximately 570,000 women were diagnosed with cervical cancer in 2018, with approximately 311,000 women dying from the disease globally. Furthermore, as per the American Cancer Society's (ACS) publication, Cancer Facts & Figures 2021, it is projected that 14,480 women will be detected with invasive cervical cancer in the United States in 2021, with 4,290 deaths due to cervical cancer.
Cost increases associated with histology tests are expected to impede market growth numbers during the analysis period. However, the increasing number of well clinical laboratories and favorable repayment regulations for cancer screening and tests in various developing areas would open up new growth avenues for market expansion.
On the other hand, increasing technological advancements in diagnostic and molecular techniques, as well as increased research and development activities, will further contribute significantly by generating huge opportunity that will contribute to the emergence of the histology and cytology industry during the forecasted timeframe.
Covid-19 Impact on Global Histology and Cytology Market
The COVID-19 pandemic is acting as a favorable driving force for market growth. Business strategy collaboration is witnessed between the businesses for developing antibodies precise for immunohistochemistry validation. Despite the fact that the COVID-19 crisis accelerated worldwide research and development efforts to combat the transmission of infection, it has brought many businesses and industries to a halt, including the healthcare industry. The histology and cytology industry was one of them. This can be explained by the changing interest of numerous clinical institutes in the development and study of potential COVID-19 treatments.
Type of examination, product, application, and region are the four categories of the global histology and cytology industry. Based on the type of examination, the segmentation includes histology, and cytology. According to our research, the cytology segment will dominate the histology and cytology market in the coming years. The incorporation of Artificial Intelligence (AI) for the development of advanced cytology systems is helping the segment.
The product segment is further categorized into consumable and reagents, and instruments and analysis software system. Among them, consumable and reagents segment achieved a significant amount of market share in 2021. Furthermore, the application segment covers into drug discovery & designing, research, and clinical diagnostics. Among them, the drug discovery & designing segment is likely to achieve the largest market share during the forecast timeframe 2022 to 2030.
Global Histology and Cytology Market Geographical Competition
The global Histology and Cytology industry is divided into North America, Europe, Latin America, Asia-Pacific, and the Middle East and Africa. Because of an increase in cancer prevalence, the North America region is anticipated to accelerate market growth. Technological advances and innovation in early disease detection are expected to drive market growth in this region. Attributed to the prevalence of a large patient pool and inhabitants in the region suffering from different infectious diseases, China and India in the APAC region is projected to have the quickest growth in the market.
Global Histology and Cytology Industry Segment Analysis
Market By Type Of Examination
o Immunohistochemistry Technique
o Microscopy Technique
o Cryostat & Microtomy Technique
o Molecular pathology Technique
o Breast Cancer
o Bladder Cancer
o Cervical Cancer
o Lung Cancer
o Other Cancers
Market By Product
· Consumable and Reagents
· Instruments and Analysis Software System
Market By Application
· Clinical Diagnostics
· Drug Discovery & Designing
Histology and Cytology Market Leading Companies
This section of the study honors the market's top companies Abbott Laboratories, Becton, Dickinson & Company, Danaher Corporation, F.Hoffmann-La Roche, Hologic, Inc., Koninklijke, Merck KGaA, Philips Healthcare, Sysmex Corporation, and Trivitron Healthcare are the key companies mentioned in the research.
Histology and Cytology Market Regions
· Rest of Europe
· Rest of Latin America
· South Korea
· Rest of Asia-Pacific
Middle East & Africa
· South Africa
· Rest of Middle East & Africa